These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 7658719

  • 1. Role for E2F1 in p210 BCR-ABL downstream regulation of c-myc transcription initiation. Studies in murine myeloid cells.
    Stewart MJ, Litz-Jackson S, Burgess GS, Williamson EA, Leibowitz DS, Boswell HS.
    Leukemia; 1995 Sep; 9(9):1499-507. PubMed ID: 7658719
    [Abstract] [Full Text] [Related]

  • 2. p120-v-Abl expression overcomes TGF-beta1 negative regulation of c-myc transcription but not cell growth.
    Birchenall-Roberts MC, Kim SJ, Bertolette DC, Turley JM, Fu T, Bang OS, Kasper JJ, Yoo YD, Ruscetti FW.
    Oncogene; 1996 Oct 03; 13(7):1499-509. PubMed ID: 8875988
    [Abstract] [Full Text] [Related]

  • 3. Cyclic AMP negatively controls c-myc transcription and G1 cell cycle progression in p210 BCR-ABL transformed cells: inhibitory activity exerted through cyclin D1 and cdk4.
    Williamson EA, Burgess GS, Eder P, Litz-Jackson S, Boswell HS.
    Leukemia; 1997 Jan 03; 11(1):73-85. PubMed ID: 9001421
    [Abstract] [Full Text] [Related]

  • 4. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
    Roussel MF, Davis JN, Cleveland JL, Ghysdael J, Hiebert SW.
    Oncogene; 1994 Feb 03; 9(2):405-15. PubMed ID: 8290253
    [Abstract] [Full Text] [Related]

  • 5. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
    Oswald F, Lovec H, Möröy T, Lipp M.
    Oncogene; 1994 Jul 03; 9(7):2029-36. PubMed ID: 8208548
    [Abstract] [Full Text] [Related]

  • 6. A direct role of transcription factor E2F in c-myc gene expression during granulocytic and macrophage-like differentiation of HL60 cells.
    Ishida S, Shudo K, Takada S, Koike K.
    Cell Growth Differ; 1995 Mar 03; 6(3):229-37. PubMed ID: 7794791
    [Abstract] [Full Text] [Related]

  • 7. Deregulation of specific E2F complexes by the v-mos oncogene.
    Afshari CA, Rhodes N, Paules RS, Mudryj M.
    Oncogene; 1997 Jun 26; 14(25):3029-38. PubMed ID: 9223666
    [Abstract] [Full Text] [Related]

  • 8. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E, Jensen MR, Thorgeirsson SS.
    Cancer Res; 1998 Jan 01; 58(1):123-34. PubMed ID: 9426068
    [Abstract] [Full Text] [Related]

  • 9. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.
    Rotheneder H, Geymayer S, Haidweger E.
    J Mol Biol; 1999 Nov 12; 293(5):1005-15. PubMed ID: 10547281
    [Abstract] [Full Text] [Related]

  • 10. The growth arrest and downregulation of c-myc transcription induced by ceramide are related events dependent on p21 induction, Rb underphosphorylation and E2F sequestering.
    Alesse E, Zazzeroni F, Angelucci A, Giannini G, Di Marcotullio L, Gulino A.
    Cell Death Differ; 1998 May 12; 5(5):381-9. PubMed ID: 10200487
    [Abstract] [Full Text] [Related]

  • 11. c-myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases.
    Alexandrow MG, Moses HL.
    J Cell Biochem; 1998 Sep 15; 70(4):528-42. PubMed ID: 9712150
    [Abstract] [Full Text] [Related]

  • 12. Autorepression of c-myc requires both initiator and E2F-binding site elements and cooperation with the p107 gene product.
    Luo Q, Li J, Cenkci B, Kretzner L.
    Oncogene; 2004 Feb 05; 23(5):1088-97. PubMed ID: 14716294
    [Abstract] [Full Text] [Related]

  • 13. Differential transcriptional regulation of c-myc promoter through the same DNA binding sites targeted by Sp1-like proteins.
    Majello B, De Luca P, Suske G, Lania L.
    Oncogene; 1995 May 04; 10(9):1841-8. PubMed ID: 7753559
    [Abstract] [Full Text] [Related]

  • 14. Regulation of adenovirus 12 E1A transcription: E2F and ATF motifs in the E1A promoter bind nuclear protein complexes including E2F1, DP-1, cyclin A and/or RB and mediate transcriptional (auto)activation.
    Kirch HC, Pützer B, Schwabe G, Gnauck HK, Schulte Holthausen H.
    Cell Mol Biol Res; 1993 May 04; 39(8):705-16. PubMed ID: 7951410
    [Abstract] [Full Text] [Related]

  • 15. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
    Eischen CM, Packham G, Nip J, Fee BE, Hiebert SW, Zambetti GP, Cleveland JL.
    Oncogene; 2001 Oct 25; 20(48):6983-93. PubMed ID: 11704823
    [Abstract] [Full Text] [Related]

  • 16. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.
    Alevizopoulos K, Vlach J, Hennecke S, Amati B.
    EMBO J; 1997 Sep 01; 16(17):5322-33. PubMed ID: 9311992
    [Abstract] [Full Text] [Related]

  • 17. Vitamin E succinate inhibits proliferation of BT-20 human breast cancer cells: increased binding of cyclin A negatively regulates E2F transactivation activity.
    Turley JM, Ruscetti FW, Kim SJ, Fu T, Gou FV, Birchenall-Roberts MC.
    Cancer Res; 1997 Jul 01; 57(13):2668-75. PubMed ID: 9205075
    [Abstract] [Full Text] [Related]

  • 18. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
    Benaud CM, Dickson RB.
    Oncogene; 2001 Jul 27; 20(33):4554-67. PubMed ID: 11494151
    [Abstract] [Full Text] [Related]

  • 19. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D, Masri S, Ye JJ, Chen S.
    Gene; 2005 Nov 21; 361():89-100. PubMed ID: 16181749
    [Abstract] [Full Text] [Related]

  • 20. BCR/ABL confers growth factor independence upon a murine myeloid cell line.
    Mandanas RA, Boswell HS, Lu L, Leibowitz D.
    Leukemia; 1992 Aug 21; 6(8):796-800. PubMed ID: 1379313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.